Applied Genetic Technologies (AGTC) Reports Q3 EPS of $0.63
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Applied Genetic Technologies Corp. (AGTC) PT More than Doubled to $12 at H.C. Wainwright
May 7, 2019 10:52 AM EDTH.C. Wainwright analyst Joseph Pantginis raised the price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $12.00 (from $5.75) while maintaining a Buy rating.
Pantginis commented, "This morning, AGTC announced F3Q19 results, posting EPS of $0.63 compared with our estimate of ($0.57) and consensus of... More
